TARA (TARA) Stock Price & Analysis
TARA (TARA) rose 0.00% to USD 4.02 as of July 25, 2026 at 03:38 UTC, according to Nexqual real-time market data.
TARA last closed at USD 4.02; the session ranged USD 3.94–4.09 on volume of 432,586 shares. Market capitalization is —, with a 52-week range of USD 2.97–7.82 (NGM). Source: Nexqual, July 25, 2026 at 03:38 UTC.
Key Statistics (as of July 25, 2026 at 03:38 UTC)
| Price | USD 4.02 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 4.02 |
| Open | USD 4.02 |
| Day Range | USD 3.94 – 4.09 |
| 52-Week Range | USD 2.97 – 7.82 |
| Volume | 432,586 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (TARA)
Nexqual's technical model rates TARA "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 03:38 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 45.6 (neutral) |
| vs SMA50 | Below (USD 4.26) |
| MACD | -0.05 (negative) |
From TARA's Latest SEC 10-K Filing (filed 2026-03-10)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LRMR | Larimar Therapeutics, Inc. | USD 4 | ▼ 0.5% |
| TRVI | Trevi Therapeutics, Inc. | USD 17.54 | ▲ 1.01% |
| CYCN | Cyclerion Therapeutics, Inc. | USD 3.5 | ▼ 3.58% |
| MNPR | Monopar Therapeutics Inc. | USD 109.87 | ▼ 2.32% |
| PMVP | PMV Pharmaceuticals, Inc. | USD 1.24 | ▼ 6.77% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:38 UTC. This page is informational and not investment advice.